Literature DB >> 7523294

Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells.

B König1, A Ludwig, W Goebel, W König.   

Abstract

The Escherichia coli alpha-hemolysin represents a potent stimulus for inflammatory mediator release (O2-, beta-glucuronidase release, and leukotriene generation) from human polymorphonuclear granulocytes, for histamine release from a suspension of human lymphocyte/monocyte basophil cells (LMB), and for serotonin release and 12-hydroxyeicosatetraenoic acid generation from human platelets. In contrast, the E. coli alpha-hemolysin leads to a downregulation of cytokine release (interleukin-1 beta [IL-1 beta], IL-6, and tumor necrosis factor alpha) from human LMB. Recently, it became apparent that the E. coli alpha-hemolysin is composed of several functional structures. We analyzed the role of pore formation, pore stability, and calcium-dependent membrane binding for inflammatory mediator release by using washed bacteria as well as culture supernatants of isogenic recombinant E. coli strains expressing no hemolysin (Hly-), the wild-type hemolysin (Hly+), or hemolysin molecules deficient or modulated in defined functions (pore formation, calcium-dependent membrane binding, or pore stability). In human granulocytes and platelets, mutant hemolysin with enhanced pore stability did not lead to a further increase in induction; mutant hemolysin deficient in pore-forming activity or calcium-dependent membrane binding no longer induced leukotriene B4 generation or beta-glucuronidase release compared with the wild-type hemolysin. Similar results were obtained with regard to histamine release from human LMB. The induction of cytokine release from human LMB differed depending on the type of mutant E. coli alpha-hemolysin. The wild-type hemolysin, the mutant hemolysin with enhanced pore-forming activity, and, to a lesser degree, the mutant hemolysin deficient in pore-forming activity decreased cytokine release (IL-1 beta, IL-6, IL-8, and tumor necrosis factor) compared with untreated cells. In contrast, the mutant hemolysin deficient in calcium-dependent membrane binding led to an increase of up to 50% in cytokine release compared with that by unstimulated cells. Our results indicate that simultaneous expression of the pore-forming and calcium-dependent membrane-binding activities of the hemolysin molecule was necessary to obtain the full cellular inflammatory response pattern observed with the wild-type hemolysin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523294      PMCID: PMC303150          DOI: 10.1128/iai.62.10.4611-4617.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Influence of cloned Escherichia coli hemolysin genes, S-fimbriae and serum resistance on pathogenicity in different animal models.

Authors:  J Hacker; H Hof; L Emödy; W Goebel
Journal:  Microb Pathog       Date:  1986-12       Impact factor: 3.738

2.  Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1.

Authors:  I G Colditz; R D Zwahlen; M Baggiolini
Journal:  J Leukoc Biol       Date:  1990-08       Impact factor: 4.962

Review 3.  Hydroxyeicosatetraenoic acids (HETEs).

Authors:  A A Spector; J A Gordon; S A Moore
Journal:  Prog Lipid Res       Date:  1988       Impact factor: 16.195

Review 4.  The role of cachectin/TNF in endotoxic shock and cachexia.

Authors:  A Cerami; B Beutler
Journal:  Immunol Today       Date:  1988-01

5.  Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes.

Authors:  J V Castell; M J Gómez-Lechón; M David; T Andus; T Geiger; R Trullenque; R Fabra; P C Heinrich
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

6.  The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes.

Authors:  A Ludwig; T Jarchau; R Benz; W Goebel
Journal:  Mol Gen Genet       Date:  1988-11

7.  Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines.

Authors:  J Willems; M Joniau; S Cinque; J van Damme
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

Review 8.  Biological and clinical aspects of interleukin 6.

Authors:  T Hirano; S Akira; T Taga; T Kishimoto
Journal:  Immunol Today       Date:  1990-12

9.  IL-8 in septic shock, endotoxemia, and after IL-1 administration.

Authors:  K J Van Zee; L E DeForge; E Fischer; M A Marano; J S Kenney; D G Remick; S F Lowry; L L Moldawer
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

10.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8.

Authors:  F Bazzoni; M A Cassatella; F Rossi; M Ceska; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  11 in total

1.  Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro.

Authors:  P K Stevens; C J Czuprynski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  The cytotoxic fimbrial structural subunit of Xenorhabdus nematophila is a pore-forming toxin.

Authors:  Jyotirmoy Banerjee; Jitendra Singh; Mohan Chandra Joshi; Shubhendu Ghosh; Nirupama Banerjee
Journal:  J Bacteriol       Date:  2006-09-01       Impact factor: 3.490

Review 3.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

4.  Occurrence of hlyA and sheA genes in extraintestinal Escherichia coli strains.

Authors:  Monika Kerényi; Heather E Allison; István Bátai; Agnes Sonnevend; Levente Emödy; Nóra Plaveczky; Tibor Pál
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae.

Authors:  E Maier; N Reinhard; R Benz; J Frey
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Binding of Pasteurella haemolytica leukotoxin to bovine leukocytes.

Authors:  J F Brown; F Leite; C J Czuprynski
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 7.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

Review 8.  Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

9.  Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.

Authors:  Chamutal Gur; Shunit Coppenhagen-Glazer; Shilo Rosenberg; Rachel Yamin; Jonatan Enk; Ariella Glasner; Yotam Bar-On; Omer Fleissig; Ronit Naor; Jawad Abed; Dror Mevorach; Zvi Granot; Gilad Bachrach; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

Review 10.  Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins.

Authors:  Katerina Filipi; Waheed Ur Rahman; Adriana Osickova; Radim Osicka
Journal:  Microorganisms       Date:  2022-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.